William M Rosenberg

William M Rosenberg

UNVERIFIED PROFILE

Are you William M Rosenberg?   Register this Author

Register author
William M Rosenberg

William M Rosenberg

Publications by authors named "William M Rosenberg"

Are you William M Rosenberg?   Register this Author

42Publications

954Reads

28Profile Views

The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis.

Aliment Pharmacol Ther 2019 Jul 31;50(2):204-214. Epub 2019 May 31.

NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals, NHS Trust and the University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15296DOI Listing
July 2019

The enhanced liver fibrosis (ELF) test in diagnosis and management of liver fibrosis.

Br J Hosp Med (Lond) 2018 Dec;79(12):694-699

Professor of Liver Medicine, The Institute for Liver and Digestive Health, University College London Division of Medicine, University College London, London.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12968/hmed.2018.79.12.694DOI Listing
December 2018

Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients.

J Hepatol 2018 09 8;69(3):603-607. Epub 2018 Jun 8.

Liver Unit, Hospital Clinic, CIBEREHD and IDIBAPS, University of Barcelona, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.05.039DOI Listing
September 2018

A Rapid and Robust Diagnostic for Liver Fibrosis Using a Multichannel Polymer Sensor Array.

Adv Mater 2018 Jul 24;30(28):e1800634. Epub 2018 May 24.

Department of Chemistry, University of Massachusetts Amherst, 710 North Pleasant Street, Amherst, MA, 01003, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/adma.201800634DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433391PMC
July 2018

Biomarkers of Hepatic Fibrosis in Chronic Hepatitis C: A Comparison of 10 Biomarkers Using 2 Different Assays for Hyaluronic Acid.

J Clin Gastroenterol 2017 Mar;51(3):268-277

*Institute for Liver & Digestive Health, University College London ‡Department of Clinical Microbiology and Virology, University College London Hospitals NHS Foundation Trust, London †Public Health Sciences and Medical Statistics, University of Southampton, Southampton, UK §Department of Medicine 1, University of Erlangen, Erlangen ¶Institute of Molecular and Translational Medicine #Department of Medicine **Research Center for Immunology (FZI), University of Mainz, Mainz, Germany ∥Institute of Pathology, Paracelsus Medical University/Salzburger Landeskliniken (SALK), Muellner Hauptstrasse 48, 5020 Salzburg, Austria ††Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MCG.0000000000000581DOI Listing
March 2017

Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.

Eur J Gastroenterol Hepatol 2017 Mar;29(3):289-296

aDivision of Medicine, Institute for Liver and Digestive Health, University College London bDepartment of Clinical Microbiology and Virology, University College London Hospitals NHS Foundation Trust, London cDepartment of Public Health Sciences and Medical Statistics, Faculty of Medicine, University of Southampton, Southampton, UK dDepartment of Medicine 1, University of Erlangen, Erlangen eInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry fDepartment of Medicine, Research Center for Immunology (FZI), University of Mainz, Mainz, Germany gInstitute of Pathology, Paracelsus Medical University/Salzburger Landeskliniken (SALK), Salzburg, Austria hDivision of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000000789DOI Listing
March 2017

Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.

J Infect Dis 2016 Apr 29;213(7):1079-86. Epub 2015 Nov 29.

Department of Medicine, University of California Medical Service, Department of Veteran Affairs Medical Center, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiv567DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779303PMC
April 2016

Equilibrium contrast-enhanced CT imaging to evaluate hepatic fibrosis: initial validation by comparison with histopathologic sampling.

Radiology 2015 Apr 8;275(1):136-43. Epub 2014 Dec 8.

From the UCL Centre for Medical Imaging (S.B., S.P., S.A.T.), UCL Institute for Liver and Digestive Health, Division of Medicine (W.M.R., R.J.), and UCL Institute for Cardiovascular Science (J.C.M.), University College London, Gower St, London WC1E 6BT, England; and Department of Cellular Pathology, UCL Medical School, Royal Free Campus, London, England (A.R.H., A.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.14141435DOI Listing
April 2015

Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver fibrosis.

Am J Gastroenterol 2015 Jan 23;110(1):159-69. Epub 2014 Dec 23.

Section of Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2014.370DOI Listing
January 2015

Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality.

BMC Gastroenterol 2014 Aug 7;14:137. Epub 2014 Aug 7.

NIHR Biomedical Research Unit in Gastrointestinal and Liver Diseases, Nottingham University Hospitals NHS Trust and The University of Nottingham, Nottingham NG7 2UH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-230X-14-137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128826PMC
August 2014

Evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests to detect significant fibrosis due to chronic hepatitis C.

J Clin Gastroenterol 2014 Apr;48(4):370-6

*Department of Pathology, University of Texas Medical Branch, Galveston **Internal Medicine, Division of Gastroenterology, Kelsey-Seybold Clinic, Houston, TX †Hernando Gastroenterology Associates, Brooksville, FL ‡Riverside Health System, 805 Progress Court, Newport News, VA §Public Health and Medical Statistics, University of Southampton, Southampton ∥iQur Limited ¶Division of Medicine, The Institute for Liver and Digestive Health, University College London, London, UK #Department of Pathology, University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0b013e3182a87e78DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947711PMC
April 2014

Treatment decisions and contemporary versus pending treatments for hepatitis C.

Nat Rev Gastroenterol Hepatol 2013 Dec 10;10(12):713-28. Epub 2013 Sep 10.

UCL Institute for Liver and Digestive Health, Royal Free London NHS Foundation Trust, Rowland Hill Street, London NW3 2PF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2013.163DOI Listing
December 2013

Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals.

BMC Pregnancy Childbirth 2013 Dec 1;13:222. Epub 2013 Dec 1.

Department of Clinical Microbiology and Virology, University College London Hospitals NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2393-13-222DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879069PMC
December 2013

[What is EBM and what is not?].

Neuere Med Wiss Quellen Stud 2012 ;22:13-7

View Article

Download full-text PDF

Source
July 2012

Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation.

Biochem Biophys Res Commun 2011 Apr 15;407(2):277-82. Epub 2011 Feb 15.

Liver and Pancreas Group, University of Southampton, Division of Infection, Inflammation and Immunity, Southampton General Hospital, Southampton, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0006291X1100192
Publisher Site
http://dx.doi.org/10.1016/j.bbrc.2011.02.009DOI Listing
April 2011

A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis.

Clin Gastroenterol Hepatol 2011 Feb 1;9(2):150-5. Epub 2010 Oct 1.

Department of Pediatric Gastroenterology, Cleveland Clinic, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S154235651000906
Publisher Site
http://dx.doi.org/10.1016/j.cgh.2010.09.015DOI Listing
February 2011

Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

Gastroenterology 2009 Jan 20;136(1):160-7. Epub 2008 Sep 20.

Liver Unit, Bambino Gesù Children's Hospital and Research Institute, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2008.09.013DOI Listing
January 2009

Renal hepatitis C in the absence of detectable serum or hepatic virus.

Liver Int 2008 Jul;28(6):889-91

Liver Research Group, Division of Infection, Inflammation and Repair, Southampton General Hospital, University of Southampton, Southampton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-3231.2008.01672.xDOI Listing
July 2008

Serum markers detect the presence of liver fibrosis: a cohort study.

Gastroenterology 2004 Dec;127(6):1704-13

Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, England SO16 6YD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2004.08.052DOI Listing
December 2004

Rating fibrosis progression in chronic liver diseases.

J Hepatol 2003 Mar;38(3):357-60

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0168-8278(03)00010-2DOI Listing
March 2003

Assessment and management of chronic hepatitis C infection.

Clin Med (Lond) 2002 Jul-Aug;2(4):302-6

Queen Alexandra Hospital, Portsmouth.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4953384PMC
http://dx.doi.org/10.7861/clinmedicine.2-4-302DOI Listing
January 2003

Success in treating mild chronic hepatitis C: different outcomes -- new guidelines?

Eur J Gastroenterol Hepatol 2002 Jun;14(6):595-7

University of Southampton, Southampton General Hospital, Southampton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00042737-200206000-00003DOI Listing
June 2002